High-throughput microelectrode array (MEA) and impedance equipment
About This Opportunity
Supplies contract award: High-throughput microelectrode. By University of Helsinki in Finland, ICT & digital. Awarded to Axion Biosystems (EIN 30-0472344).
This is a supplies contract in the information and communication technology, energy and power and environment and climate sectors, with a focus on Oil Gas and Software. Located in Finland, Europe, this opportunity is open to firms and consortiums.
Published through Hilma Finland, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the information and communication technology sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
High-throughput microelectrode array (MEA) and impedance equipment High-throughput microelectrode array (MEA) and impedance equipment will be acquired for University of Helsinki (new notice with an updated price).
Microelectrode array (MEA) systems are novel tools in electrophysiology that will help the basic and preclinical research on brain and cardiac diseases with a goal to efficiently translate preclinical research findings into efficient treatment, prevention and diagnosis. Electrophysiological techniques allow comprehensive understanding of the biological basis of functioning of these cell types in health and in pathological conditions. MEA technology is one of the core methods to study e.g. electrophysiological characteristics of neuronal and cardiac cells and their function both in normal and diseased conditions. High-throughput MEA instruments allow also drug discovery for neurological and cardiovascular diseases and investigation of novel therapeutic targets/treatments in human cell-based models in vitro. Instrument with integrated impedance technology allows also cell viability and neuro/cardio-toxicity analysis, which are highly relevant for early safety assessment of new drug leads.
Minimum technical specifications required from the high-throughput microelectrode array (MEA) and impedance equipment to be purchased are:
• Enables medium to high throughput analysis i.e. at least 96-well format capacity. This throughput is needed for screening compound libraries where compound stock volumes are limited.
• Enables measurements with several plate formats mimicking standard well culture plates (at least 12, 24, 48, 96 well formats). This flexibility is required to enable experiments with various cell models some of which cannot be established in high-throughput format
• >700 measurement electrodes per MEA plate to allow high quality data output with high number of electrodes per well
• At least 12.5 kHz data sampling frequency to identify fast occurring electrophysiological events in neuronal and cardiac cells
• Ability to induce and measure cardiac local extracellular action potentials (LEAP) on any and every electrode in a plate
• Capable of monitoring live cell function parameters in real time including cell proliferation, cytotoxicity, cell adhesion, receptor based functional assays, immune cell killing, ADCC, viral neutralizing antibody detection, cell migration, wound healing, and barrier function through impedance with at least 96-well plate capacity
• Optogenetic stimulator for customizable light stimulation
• Temperature and gas environment control for measurement chamber to enable stable long-term measurements
• Option for transparent sample area in wells for imaging cell growth, morphology for identification
• Possibility to use customised MEA plates, e.g. organ-on-a-chip platforms for co-cultures and tissue models
• Advanced, license-free analysis software packages specifically designed for neuronal and cardiac cell analysis, cell viability and impedance measurements.,
Lot 1: High-throughput microelectrode array (MEA) and impedance equipment
High-throughput microelectrode array (MEA) and impedance equipment will be acquired for University of Helsinki (new notice with an updated price).
Microelectrode array (MEA) systems are novel tools in electrophysiology that will help the basic and preclinical research on brain and cardiac diseases with a goal to efficiently translate preclinical research findings into efficient treatment, prevention and diagnosis. Electrophysiological techniques allow comprehensive understanding of the biological basis of functioning of these cell types in health and in pathological conditions. MEA technology is one of the core methods to study e.g. electrophysiological characteristics of neuronal and cardiac cells and their function both in normal and diseased conditions. High-throughput MEA instruments allow also drug discovery for neurological and cardiovascular diseases and investigation of novel therapeutic targets/treatments in human cell-based models in vitro. Instrument with integrated impedance technology allows also cell viability and neuro/cardio-toxicity analysis, which are highly relevant for early safety assessment of new drug leads.
Minimum technical specifications required from the high-throughput microelectrode array (MEA) and impedance equipment to be purchased are:
• Enables medium to high throughput analysis i.e. at least 96-well format capacity. This throughput is needed for screening compound libraries where compound stock volumes are limited.
• Enables measurements with several plate formats mimicking standard well culture plates (at least 12, 24, 48, 96 well formats). This flexibility is required to enable experiments with various cell models some of which cannot be established in high-throughput format
• >700 measurement electrodes per MEA plate to allow high quality data output with high number of electrodes per well
• At least 12.5 kHz data sampling frequency to identify fast occurring electrophysiological events in neuronal and cardiac cells
• Ability to induce and measure cardiac local extracellular action potentials (LEAP) on any and every electrode in a plate
• Capable of monitoring live cell function parameters in real time including cell proliferation, cytotoxicity, cell adhesion, receptor based functional assays, immune cell killing, ADCC, viral neutralizing antibody detection, cell migration, wound healing, and barrier function through impedance with at least 96-well plate capacity
• Optogenetic stimulator for customizable light stimulation
• Temperature and gas environment control for measurement chamber to enable stable long-term measurements
• Option for transparent sample area in wells for imaging cell growth, morphology for identification
• Possibility to use customised MEA plates, e.g. organ-on-a-chip platforms for co-cultures and tissue models
• Advanced, license-free analysis software packages specifically designed for neuronal and cardiac cell analysis, cell viability and impedance measurements.
CPV: 38000000
Organisation: University of Helsinki
Procedure: neg-wo-call
Data provenance
This notice is sourced from Hilma Finland and was originally published on March 17, 2026. Last refreshed 1 day ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About University of Helsinki
University of Helsinki has issued 12 procurement notices on BidsFactory, including 1 currently open and 5 awarded contracts. Activity concentrates in Environment & Climate, Research & Innovation, and Health & Medical. All notices are published for Finland. Notices are distributed via Hilma Finland and TED - Tenders Electronic Daily (EU). Most recent publication: May 8, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Finland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Hilma Finland to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Axion Biosystems (EIN 30-0472344). The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by University of Helsinki in Finland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Information & Communication Technology sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.